Alfasigma's $800 million buyout of Intercept Pharma two years ago is starting to look like a poor bet, as its only approved product, Ocaliva, is pulled off the market in the US and all trials of the ...

Tucson will become the new headquarters for a combined business unit made up of Tucson-based Raytheon Missile Systems and a Massachusetts-based Raytheon business when parent Raytheon Co. and United ...